Concepedia

Ferdinando Frigeri

FF

29

Publications

1.4K

Citations

19

H-Index

1993

Active since

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Federico II University Hospital

University of Naples Federico II

Ceinge Biotecnologie Avanzate (Italy)

Ospedale Antonio Cardarelli

Ferdinando Frigeri is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

1993–2024

29

Publications

29

Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) [see comments]

Fabrizio Pane, Ferdinando Frigeri, M Sindona et al. · Blood · 1996 · 387 citations

<sup>90</sup>Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial

Christian W. Scholz, Werner Linkesch, Ola Lindén et al. · Journal of Clinical Oncology · 2012 · 108 citations · Full text

Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis

Giuseppe Saglio, Fabrizio Pane, Enrico Gottardi et al. · Blood · 1996 · 104 citations · Full text

RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma

Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo et al. · British Journal of Haematology · 2011 · 76 citations

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone et al. · Cancer Chemotherapy and Pharmacology · 2009 · 75 citations

, , +8

Rows per page

1–5 of 29